Skip to main content
. 2023 Sep 1;3(9):e0001989. doi: 10.1371/journal.pgph.0001989

Table 1. Study population.

  All Pre-Xpert* Xpert
N = 749 N = 247 N = 502
Sex = Female (%) 367 0.48 126 51 241 48
age (mean (SD)) 38.19 11.28 37.93 10.53 38.31 11.65
BMI (mean (SD)) 20.20 6.19 20.73 5.64 19.89 6.49
Risk factors(%)          
    none reported 616 82.2 196 79.4 420 83.7
    Family/friend with MDR-TB 111 14.8 43 17.4 68 13.5
    Worked at clinic/hospital 22 2.9 8 3.2 14 2.8
Province (%)          
    Gauteng 236 31.5 81 32.8 155 30.9
    Free State 192 25.6 51 20.6 141 28.1
    Western Cape 321 42.9 115 46.6 206 41.0
Employment (%)          
    No 351 46.9 116 47 235 46.8
    Yes 117 15.6 40 16.2 77 15.3
    other 281 37.5 91 36,8 190 37,8
Substance abuse (%) 26 3.5 5 2 21 4.2
Diabetes Mellitus (%) 28 3.7 10 4 18 3.6
Mental Health Concerns (%) 31 4.1 10 4 21 4.2
HIV status (%)          
    negative 144 19.2 45 18.2 99 19.7
    positive 581 77.6 194 78.5 387 77.1
    unknown 24 3.2 8 3.2 16 3.2
CD4 (median [IQR]) 133.00 51.50, 276.50 128.00 51.00, 307.50 135.50 52.00, 272.25
Baseline log viral load (mean (SD)) 4.56 1.49 4.33 1.55 4.75 1.43
Baseline ART status (%)          
    ART interrupted 42 7.2 13 6.7 29 7.5
    ART naïve 187 32.2 62 32 125 32.3
    on ART at diagnosis 193 33.2 62 32 131 33.9
    Unknown 159 27.4 57 29.4 102 26.4
TB type (%)          
    Pulmonary TB (PTB) 689 92.0 223 90.3 466 92.8
    Extrapulmonary TB (EPTB) 7 0.9 3 1.2 4 0.8
    PTB+EPTB 53 7.1 21 8.5 32 6.4
Newly diagnosed (%)          
    Newly diagnosed 303 40.5 80 32.4 223 44.4
    Retreatment 391 52.2 148 59.9 243 48.4
    Unknown 55 7.3 19 7.7 36 7.2
Retreatment type (%)     n = 148 n = 242
    Cured 21 54.3 69 46.6 143 59.1
    Defaulted 87 22.36 43 29.1 44 18.2
    Treatment failure 18 4.6 10 6.8 8 3.3
    Other 73 18.7 26 17.6 47 19.4
Smear status (%)          
    Negative 333 44.5 96 38.9 237 47.2
    No smear info 80 10.7 17 6.9 63 12.5
    Positive 336 44.9 134 54.3 202 40.2

* targeted LPA based RR-TB diagnostic algorithm.